CureVac NV (5CV) — Cash Flow Quality Index
Latest as of September 2025:
0.11x
CureVac NV (5CV) has a Cash Flow Quality Index of 0.11x as of September 2025. Operating cash flow of €29.86 Million is below net income of €273.23 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CureVac NV (5CV) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.11x
Operating CF / Net Income
Operating Cash Flow
€29.86 Million
EUR
Net Income
€273.23 Million
EUR
Data as of
Sep 2025
Most recent filing
CureVac NV Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for CureVac NV across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CureVac NV cash conversion from operations.
Annual Cash Flow Quality Index for CureVac NV (2024–2024)
Year-by-year earnings quality comparison for CureVac NV.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.63x | €101.85 Million | €162.19 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.